The negative experience of somatostatin synthetic analogist using in therapy of policystoc ovaries

D. V. Grinvald , А. A. Kirsanov , А. R. Kasumova , М. V. Bondarenko

Journal of obstetrics and women's diseases ›› 2005, Vol. 54 ›› Issue (2) : 40 -43.

PDF
Journal of obstetrics and women's diseases ›› 2005, Vol. 54 ›› Issue (2) : 40 -43. DOI: 10.17816/JOWD81809
Original study articles
research-article

The negative experience of somatostatin synthetic analogist using in therapy of policystoc ovaries

Author information +
History +
PDF

Abstract

The blood content of insulin—like growth factor—1 (IGF—1) in woman with ovarian hyperstimulation syndrome (OHSS) is low that may be connect with damage of synthetic function of liver. The use of synthetic analogist of somatostatin in treatment of OHSS don’t lead to reliable positive results. Low content of IGF—1 in OHSS makes pathogeneticaly non—justifight the treatment of OHSS by synthetic analogist of somatostatin.

Keywords

ovarian hyperstimulation syndrome (OHSS) / insulin—like growth factor—1 (IGF—1) / somatostatin / induction of ovulation

Cite this article

Download citation ▾
D. V. Grinvald,А. A. Kirsanov,А. R. Kasumova,М. V. Bondarenko. The negative experience of somatostatin synthetic analogist using in therapy of policystoc ovaries. Journal of obstetrics and women's diseases, 2005, 54(2): 40-43 DOI:10.17816/JOWD81809

登录浏览全文

4963

注册一个新账户 忘记密码

References

RIGHTS & PERMISSIONS

Eсо-Vector

AI Summary AI Mindmap
PDF

0

Accesses

0

Citation

Detail

Sections
Recommended

AI思维导图

/